INSULINA LISPRO BULA PDF
aplicação de insulina em diabéticos.1 . *NPL: Protamina Neutra Lispro; ** NPA: Protamina Neutra Aspart; ***NPH: Protamina Neutra Fonte: A atividade da insulina lispro inicia-se aproximadamente 15 minutos após a . médico e leve a embalagem ou bula do medicamento, se possível. Ligue para. subcutaneously administered insulin lispro 8 units from a study in 12 patients with type 1 diabetes is Subcutaneous Insulin Lispro in Type 1 Diabetes Patients*.
| Author: | Zuramar Gogor |
| Country: | Congo |
| Language: | English (Spanish) |
| Genre: | Science |
| Published (Last): | 15 September 2014 |
| Pages: | 199 |
| PDF File Size: | 15.47 Mb |
| ePub File Size: | 4.45 Mb |
| ISBN: | 241-5-64243-721-3 |
| Downloads: | 60215 |
| Price: | Free* [*Free Regsitration Required] |
| Uploader: | Togal |
Insulin requirements and dosage adjustment Insulin requirements may be increased during illness or emotional disturbances. Uncorrected hypoglycaemic or hyperglycaemic reactions can cause loss of consciousness, coma, or death. Insulin lispro maintains more rapid absorption when compared to soluble human insulin in patients with renal impairment. Transferring a patient to another type or brand of insulin should be done under strict medical supervision. Date of revision of the text.
Insulin lispro has been shown to be equipotent to human insulin on a molar basis but its effect is more rapid and of a shorter duration.
Hipoglicemiante
Patients should be advised to take precautions to avoid hypoglycaemia whilst driving. In patients with type 2 diabetes over a wide range of renal function the pharmacokinetic differences between insulin lispro and soluble human insulin were generally maintained and shown to be independent of renal function.
Pioglitazone should be discontinued, if any deterioration in cardiac symptoms occurs. Combination of Humalog with pioglitazone Cases of cardiac failure have been reported when pioglitazone was used in combination with insulin, especially in patients with risk factors for development of cardiac heart failure.
Reporting suspected adverse reactions after authorisation of the medicinal product is important. Overdose can luspro causing lislro hypoglycemia. In patients with type 2 diabetes on maximum doses of sulphonyl urea agents, studies have shown that the addition of insulin lispro significantly reduces HbA1c compared to sulphonyl urea alone.
Sustained carbohydrate intake and observation may be necessary because hypoglycaemia may recur after apparent clinical recovery.
Studies also demonstrate that the dissociation of binding to the insulin receptor of insulin lispro is equivalent to human insulin.
Strengths Available for Humalog |
The glucodynamic response to insulin lispro is not affected by renal or hepatic function impairment. Insulins have no specific overdose definitions because serum glucose concentrations are a result of complex interactions between insulin levels, glucose availability and other metabolic processes.
Date of first authorisation: This information is intended for use by health professionals. Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Patients with diabetes who are breast-feeding may require adjustments in insulin dose, diet or both. Before using the KwikPen the user manual included in the lisprro leaflet must be read carefully. Careful monitoring of glucose control, as well as general health, is essential in pregnant patients with diabetes.
The reduction of HbA1c would also be expected with other insulin products e. Hypoglycaemia may occur as a result of an excess of bual activity relative to food intake and energy expenditure.
Time to maximum concentration was also similar between formulations. Prescription Drug Search Strengths available for Humalog cartridge: Adjustment of dosage may also be necessary if patients undertake increased physical activity or change their usual diet.
After injection, the site of injection should insuliina be massaged. A10AB04 The primary activity of insulin lispro is the regulation of glucose metabolism. Humalog may be given shortly before meals.
Posology The dosage should be determined by the physician, according to the requirement of the patient. This condition usually resolves in a few days to a few weeks. Use of injection sites should be rotated so that the same site is not used more than approximately once a month. Hepatic impairment Insulin requirements may be reduced in patients with hepatic impairment due to reduced capacity for gluconeogenesis and reduced insulin breakdown; however, in patients with chronic hepatic impairment, an ineulina in insulin resistance may lead to increased insulin requirements.
However, glucose solution must be given intravenously bua glucagon is not available or if the patient fails to respond to glucagon. Active ingredient insulin lispro. The Humalog solution should be clear and colourless.
Humalog 200 Units/ml KwikPen, solution for injection in pre-filled pen
Customer Service Use ref Contact Form. The number of insulin units is shown bulla the dose window of the pen regardless of strength and no dose conversion should be done when transferring a patient to a lisro strength or to a pen with a different dose step. Yellow Card Scheme, website: The patient should discard the needle after every injection.
In in vitro tests, including binding to insulin receptor sites and effects on growing cells, insulin lispro behaved in a manner that closely resembled human insulin. Patients must be instructed to always check the insulin label before each injection to avoid accidental mix-ups between the two different strengths of Humalog as well as other insulin products.
Hipoglicemiante – Wikipédia, a enciclopédia livre
Insulin lispro takes effect rapidly and has a shorter duration of activity 2 to 5 hours when compared to soluble insulin. Sign Up Log In Cancel.
Hypoglycaemia is the most frequent adverse reaction of insupina lispro therapy that a patient with diabetes may suffer. The use of dosages which are inadequate or discontinuation of treatment, especially in insulin-dependent diabetics, may lead to hyperglycaemia and diabetic ketoacidosis; conditions which are potentially lethal.